Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Filings indexed 803 across all filing types
Latest filing 2022-10-12 Capital/Financing Update
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding a decision to increase short-term borrowings ('단기차입금증가결정'). It details the amount, purpose, and board approval date. This falls under financing activities and capital structure changes, which is categorized as CAP (Capital/Financing Update).
2022-10-12 Korean
[기재정정]기타경영사항(자율공시)(제17회차 무기명식 이권부 무보증 사모 전환사채 재매각)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Medicox) regarding the 'resale' of previously acquired convertible bonds (CB). It details the transaction terms, counter-parties, and a correction of the disposal date. Since this relates to the company's capital structure and financing activities (specifically the disposal/resale of debt instruments), it falls under the 'Capital/Financing Update' category.
2022-10-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including conversions of convertible bonds and subsequent sales of shares by the reporting entity (SangSangIn Savings Bank) regarding the issuer (Medicox). This falls under the category of Major Shareholding Notification.
2022-10-11 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제18회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the acquisition of convertible bonds before maturity (a corporate financing event). It details the specific bond series, acquisition amount, acquisition method, and the source of funds. This falls under the category of capital and financing updates.
2022-10-07 Korean
전환청구권행사(제17회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채) issued by Medicox. It details the number of shares issued, the conversion price, and the remaining balance of the convertible bonds. This type of disclosure regarding capital structure changes and share issuance resulting from debt conversion falls under the 'Share Issue/Capital Change' category.
2022-10-07 Korean
[기재정정]기타경영사항(자율공시)(제17회차 무기명식 이권부 무보증 사모 전환사채 재매각)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding a 'Correction Report' (정정신고) for a previous disclosure about the resale of convertible bonds (제17회차 무기명식 이권부 무보증 사모 전환사채 재매각). It details changes to payment schedules and transaction terms. Since this is a specific regulatory disclosure regarding financing and capital structure changes (convertible bond resale), it falls under the 'Capital/Financing Update' category.
2022-10-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.